Harold D. Tamayo serves as Chief Financial Officer of Aspargo Labs, bringing over 20 years of financial leadership across the biopharma and healthcare sectors. He is recognized for his expertise in strategic financial planning, resource optimization, mergers and acquisitions, and operational transformation. His leadership has consistently driven financial performance and supported growth for organizations ranging from early-stage companies to publicly traded global enterprises.

Before joining Aspargo Labs, Mr. Tamayo served as CFO and Board Advisor for Neighborhood LTC Pharmacy, a rapidly expanding leader in long-term care and specialty pharmacy services. During his tenure, he spearheaded strategies that enhanced operational efficiency and positioned the company for sustained growth. Moreover, he established a robust financial and accounting infrastructure, transitioning key functions in-house to provide better financial insights and reporting for stakeholders.

Earlier in his career, Mr. Tamayo held numerous executive roles, including CFO of McKesson Prescription Technology Solutions, an SEC-reported segment, where he strengthened profitability and led transformative initiatives. As VP of Finance and Investor Relations at Axogen Inc. (NASDAQ: AXGN), he played a key role in driving the company’s market capitalization growth and operational success. His leadership experience also includes serving as CFO for CVS Omnicare and Express Scripts International, along with leadership positions at Novartis Pharma and Merck & Co., where he contributed to strategic initiatives, business development, and global expansion.

Mr. Tamayo earned a dual master’s degree in business administration and industrial engineering from the University of Miami and a Bachelor of Science in electrical engineering from Florida International University.